Medical Equipments, Pharmaceuticals And Personal Care Products Tenders

Conclusion of Non-Exclusive Discount Agreements According to §130A Para.8 Sgb V for Various Active Ingredient(S)/Combinations with the Possibility of Conclusion at any Time as Part of the So-Called Open House Procedure

Open House Original Rebate Agreements 2023-22 - Sofosbuvir, Velpatasvir, Voxilaprevir (Drug Combination)

Drug Discount Contracts According to § 130A Paragraph 8 Sgb V in the Context of Open House Procedures

Degree Non-Excl. Drug Discount Ver. According to § 130A Paragraph 8 Sgb V Iwe So-Called Open-House Model for Ws Melatonin (Atc Code who N05ch01), Restricted to the Potency/Dosage 2Mg Prolonged-Release Tablet.

Conclusion of Non-Exclusive Discount Agreements According to §§ 130A Abs. 8/130C Abs. 1 Sgb V for Drugs with the Active Ingredient Fluorouracil (D11af05) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with §§ 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Formoterol and Glycopyrronium Bromide (R03al07) as Part of an Open House Model.

Degree Non-Excl. Drug Discount Ver. According to § 130A Paragraph 8 Sgb V Iwe So-Called Open-House Model for Ws Melatonin (Atc Code who N05ch01), Restricted to the Potency/Dosage 2Mg Prolonged-Release Tablet.

Conclusion of Non-Exclusive Drug Discount Agreements According to § 130A Para. 8 Sgb V by Means of a So-Called Open House Model for the Active Ingredient Tacrolimus (Atc Code According to Who: D11ah01)

Disposable Scopes Dps

Rigid Endoscopy 2021-2026 (Dps)